Medications for Hypogonadism
34 results
Androderm (testosterone)
(Testosterone)Allergan, Inc.
Usage: ANDRODERM is indicated for replacement therapy in adult males with testosterone deficiency due to primary hypogonadism or hypogonadotropic hypogonadism. It is not approved for age-related hypogonadism or use in males under 18 years old.
Androgel (testosterone)
(Testosterone)ASCEND Therapeutics U.S., LLC
Usage: AndroGel 1.62% is indicated for replacement therapy in adult males with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., pituitary injury). Its safety and efficacy in age-related hypogonadism and males under 18 have not been established.
Aveed (testosterone undecanoate)
(testosterone undecanoate)ENDO USA, Inc.
Usage: AVEED is indicated for testosterone replacement therapy in adult males with testosterone deficiency due to primary or hypogonadotropic hypogonadism. It is essential for patients who need therapy, considering the benefits against risks like POME and anaphylaxis. Not approved for age-related hypogonadism or use in males under 18.
Azmiro (testosterone cypionate)
(TESTOSTERONE CYPIONATE)Azurity Pharmaceuticals, Inc.
Usage: AZMIRO is indicated for testosterone replacement therapy in males with conditions causing testosterone deficiency, including primary hypogonadism (e.g., testicular failure, Klinefelter’s syndrome) and hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). The safety and efficacy for age-related hypogonadism and pediatric patients under 12 are not established.
Bromocriptine mesylate (bromocriptine mesylate)
(Bromocriptine mesylate)Zydus Pharmaceuticals USA Inc.
Usage: Bromocriptine mesylate capsules are indicated for treating hyperprolactinemia-related disorders (e.g., amenorrhea, infertility, hypogonadism), acromegaly, and symptoms of Parkinson's disease. It may be used with levodopa to enhance efficacy and reduce side effects, especially in patients experiencing tolerance or "end of dose failure."
Bromocriptine mesylate (bromocriptine mesylate)
(Bromocriptine mesylate)Sandoz Inc
Usage: Bromocriptine mesylate tablets are indicated for treating hyperprolactinemia-related dysfunctions (e.g., amenorrhea, infertility), acromegaly, and symptoms of Parkinson's disease. They help reduce tumor size in prolactin-secreting adenomas and enhance effects of levodopa in Parkinson's, while potentially reducing levodopa dosage and adverse reactions.
Climara (estradiol)
(Estradiol)Bayer HealthCare Pharmaceuticals Inc.
Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.
Depo-testosterone (testosterone cypionate)
(testosterone cypionate)Pharmacia and Upjohn Company LLC
Usage: DEPO-Testosterone Injection is indicated for replacement therapy in men with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., gonadotropin deficiency). Its safety and efficacy for "age-related hypogonadism" have not been established.
Estra-50 (estradiol pellet)
(Estradiol pellet)Advanced Pharmaceutical Technology, Inc.
Usage: Estradiol is indicated for treating estrogen deficiency in hysterectomized women, atrophic vaginitis, kraurosis vulvae, female hypogonadism, female castration, primary ovarian failure, and breast cancer (palliation only). It may also be used for postpartum breast engorgement, but risks must be assessed. Not effective during pregnancy.
Estradiol transdermal system (estradiol)
(Estradiol)Sandoz Inc
Usage: The Estradiol Transdermal System is indicated for treating moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from various causes, and prevention of postmenopausal osteoporosis, with specific limitations for certain conditions.